The longevity supplement market is projected to reach $44 billion by 2027, yet navigating the evidence requires careful distinction between marketing claims and actual research findings.
How Supplements Are Tested
Longevity research follows a progression: cell studies, animal models, then human trials. Many supplements showing dramatic results in mice fail to translate to human benefits. Understanding this hierarchy prevents premature enthusiasm.
Currently Promising Compounds
NAD+ Precursors (NMN, NR): Animal studies show cellular rejuvenation. Human trials demonstrate increased NAD+ levels but clinical outcomes remain inconclusive for healthy adults.
Spermidine: Found in wheat germ, aged cheese, and mushrooms. Animal data is compelling for autophagy activation, and early human trials show cognitive benefits in older adults.
Rapamycin Analogs
MTOR inhibition is perhaps the most validated longevity pathway from animal studies. Low-dose rapamycin trials in humans are underway, but the risk-benefit profile remains uncertain.
A Responsible Approach
Before supplementing, optimize the fundamentals: sleep, exercise, nutrition, and stress management deliver the largest effect sizes. Supplements should augment, not replace, these foundations.
Consult with a physician who understands longevity medicine. Monitor biomarkers before and after supplementation.
The Bigger Picture
The most powerful longevity interventions remain free: regular exercise, social connection, purpose, adequate sleep, and a whole-food diet. No supplement yet matches their combined effect.